The First Affiliated Hospital of Chongqing Medical Universty
Welcome,         Profile    Billing    Logout  
 57 Trials 
92 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zhang, Jun
HEARTRIP, NCT03809273: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI

Recruiting
4
668
RoW
Yangxinshi, Trimetazidine, Yangxinshi mimic, Trimetazidine mimic
Shenyang Northern Hospital
Percutaneous Coronary Intervention
12/20
12/20
NCT05181475: Long-term Efficacy and Safety Study of GV-971

Active, not recruiting
4
800
RoW
Sodium Oligomannate Capsules (GV-971)
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Alzheimer Disease
01/25
06/25
NCT06565715: Effect of Remazolam on Hemodynamics During Hepatectomy

Recruiting
4
70
RoW
Remimazolam, rebenin, Propofol, Propofol emulsion
Jun Zhang
Hemodynamic Instability
10/24
11/24
NCT03491059: Feasibility of PET/CT to Detect the Oral/Pulmonary Distribution of Nicotine Following E-cigarette Use

Active, not recruiting
4
2
US
C-11 labeled nicotine, PET/CT imaging
University of Cincinnati
E-cigarette Use
12/24
02/25
OPTIMA-6, NCT05410925: Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction

Recruiting
4
2260
RoW
Recombinant staphylokinase, Placebo
The First Affiliated Hospital with Nanjing Medical University
ST Elevation Myocardial Infarction
12/26
12/27
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting
4
8250
RoW
Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy
Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases
04/25
04/25
NCT04782895: Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age

Completed
3
488
RoW
Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli), Gardasil®9
Xiamen University, Xiamen Innovax Biotech Co., Ltd, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Cervical Cancer, Condylomata Acuminata
05/22
07/22
NCT04714190: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression

Recruiting
3
351
RoW
RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection, Paclitaxel injection, Taxol, Irinotecan Hydrochloride Injection, CAMPTO, Apatinib Mesylate Tablets, Aitan
RemeGen Co., Ltd.
Gastric Cancer, HER2 Overexpressing Gastric Carcinoma
12/24
06/25
PYRAMID-1, NCT04447118 / 2020-000951-11: Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

Active, not recruiting
3
151
Europe, US, RoW
Pyrotinib, Irene, Docetaxel, Docetaxel injection
Jiangsu HengRui Medicine Co., Ltd.
Non-squamous NSCLC, HER2 Exon 20 Mutation
06/23
10/23
SPH3127-301, NCT05359068: Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

Completed
3
957
RoW
SPH3127 tablet, Valsartan
Shanghai Pharmaceuticals Holding Co., Ltd
Essential Hypertension
12/23
12/23
NCT04674956: A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

Recruiting
3
401
RoW
Camrelizumab, Paclitaxel(Albumin Bound) and Gemcitabine, Placebo
RenJi Hospital
Pancreatic Cancer Stage IV, Pancreatic Cancer Metastatic
12/24
12/25
NCT05056402: An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Active, not recruiting
3
1382
RoW
3 doses of the Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli), 2 doses of theRecombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli)
Xiamen Ophthalmology Center Affiliated to Xiamen University, Xiamen Innovax Biotech Co., Ltd, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Cervical Cancer, Condylomata Acuminata
12/25
12/25
NCT05352516 / 2022-002188-31: A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

Completed
3
514
RoW
HLX14, Prolia®
Shanghai Henlius Biotech, Shanghai Henlius Biotech, Inc.
Postmenopausal
12/23
07/24
HERIZON-GEA-01, NCT05152147 / 2021-000296-36: A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

Recruiting
3
918
Europe, Canada, Japan, RoW
Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil
Jazz Pharmaceuticals, BeiGene, Ltd.
Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma
05/25
05/26
NCT06472908: Efficacy and Safety of Colchicine After PCI

Not yet recruiting
3
8862
RoW
Colchicine 0.5 mg, no other name, Colchicine 0.375 mg, Placebo
Wuhan Union Hospital, China
Coronary Heart Disease, Percutaneous Coronary Intervention, Colchicine
03/28
08/28
ACCIO, NCT04267848: Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial

Recruiting
3
1210
US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemcitabine HCI, Gemzar, LY 188011, LY-188011, LY188011, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Observation, Inspection, Visual Inspection, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK 3475, MK-3475, MK3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, Pembrolizumab Biosimilar RPH-075, QL2107, RPH 075, RPH-075, RPH075, SCH 900475, SCH-900475, SCH900475, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Questionnaire Administration
National Cancer Institute (NCI)
Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
12/25
12/25
NCT05768503: Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Recruiting
3
176
RoW
Experimental drug, CAP, Control Rx, FOLFIRI+BEV
Sun Yat-sen University
Metastatic Microsatellite-stable Colorectal Cancer
01/26
01/27
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Active, not recruiting
3
878
RoW
JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy
Shanghai Junshi Bioscience Co., Ltd.
Gastric or Esophagogastric Junction Adenocarcinoma
06/26
07/28
SUNRAY-01, NCT06119581: A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Recruiting
3
1016
Europe, Canada, Japan, US, RoW
LY3537982, Olomorasib, Pembrolizumab, Placebo, Cisplatin, Carboplatin, Pemetrexed
Eli Lilly and Company, Loxo Oncology, Inc.
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
10/26
10/29
NCT05918094: Comparing Modified XELOX Plus Sintilimab With Standard XELOX Plus Sintilimab in First-line Treatment for HER2-negative Gastric/Gastroesophageal Junction Adenocarcinoma

Recruiting
3
540
RoW
Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab
Sun Yat-sen University
Gastric Cancer
12/26
12/28
NCT04181060: Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting
3
300
US
Bevacizumab, ABP 215, ABP-215, ABP215, Alymsys, Anti-VEGF, Anti-VEGF Humanized Monoclonal Antibody, Anti-VEGF Monoclonal Antibody SIBP04, Anti-VEGF rhuMAb, Avastin, Avzivi, Aybintio, BAT 1706, BAT-1706, BAT1706, BAT1706 Biosimilar, Bevacizumab awwb, Bevacizumab Biosimilar ABP 215, Bevacizumab Biosimilar BAT1706, Bevacizumab Biosimilar BEVZ92, Bevacizumab Biosimilar BI 695502, Bevacizumab Biosimilar CBT 124, Bevacizumab Biosimilar CT-P16, Bevacizumab Biosimilar FKB238, Bevacizumab Biosimilar GB-222, Bevacizumab Biosimilar HD204, Bevacizumab Biosimilar HLX04, Bevacizumab Biosimilar IBI305, Bevacizumab Biosimilar LY01008, Bevacizumab Biosimilar MB02, Bevacizumab Biosimilar MIL60, Bevacizumab Biosimilar Mvasi, Bevacizumab Biosimilar MYL-1402O, Bevacizumab Biosimilar QL 1101, Bevacizumab Biosimilar QL1101, Bevacizumab Biosimilar RPH-001, Bevacizumab Biosimilar SCT501, Bevacizumab Biosimilar Zirabev, Bevacizumab-adcd, Bevacizumab-awwb, Bevacizumab-aybi, Bevacizumab-bvzr, Bevacizumab-equi, Bevacizumab-maly, Bevacizumab-onbe, Bevacizumab-tnjn, BP102, BP102 Biosimilar, CT P16, CT-P16, CTP16, Equidacent, FKB 238, FKB-238, FKB238, HD204, Immunoglobulin G1 (Human-Mouse Monoclonal rhuMab-VEGF Gamma-Chain Anti-Human Vascular Endothelial Growth Factor), Disulfide With Human-Mouse Monoclonal rhuMab-VEGF Light Chain, Dimer, MB 02, MB-02, MB02, Mvasi, MYL-1402O, Onbevzi, Oyavas, PF 06439535, PF-06439535, PF06439535, QL1101, Recombinant Humanized Anti-VEGF Monoclonal Antibody, rhuMab-VEGF, SCT501, SIBP 04, SIBP-04, SIBP04, Vegzelma, Zirabev, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Multigated Acquisition Scan, Blood Pool Scan, Equilibrium Radionuclide Angiography, Gated Blood Pool Imaging, Gated Heart Pool Scan, MUGA, MUGA Scan, Multi-Gated Acquisition Scan, Radionuclide Ventriculogram Scan, Radionuclide Ventriculography, RNV Scan, RNVG, SYMA Scanning, Synchronized Multigated Acquisition Scanning, Osimertinib, AZD 9291, AZD-9291, AZD9291, Mereletinib
National Cancer Institute (NCI)
Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8
12/26
12/26
NCT04537156: Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Active, not recruiting
3
9327
RoW
Nonavalent HPV vaccine, Bivalent HPV vaccine
Xiamen University, Xiamen Innovax Biotech Co., Ltd, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Cervical Intraepithelial Neoplasia, Cervical Cancer, Condylomata Acuminata
12/27
12/27
NCT03959150: Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

Recruiting
2/3
231
RoW
Capecitabine, Xeloda
Ruijin Hospital
Pancreatic Cancer
06/22
06/23
NCT02942706: Cetuximab Maintenance Treatment Versus Continuation After Induction Therapy in mCRC

Not yet recruiting
2/3
200
NA
Cetuximab, Erbitux, mFOLFOX6, FOLFIRI
Ruijin Hospital, Chinese PLA General Hospital, Xiangya Hospital of Central South University, West China Hospital, Tongji Hospital
Colorectal Cancer
10/22
10/22
NCT06221748: DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

Recruiting
2/3
90
RoW
Disitamab Vedotin Injection, DV,RC48, Cadonilimab Injection, AK104, Cadonilimab Injection, Paclitaxel Injection
RemeGen Co., Ltd.
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
12/26
12/27
NRG-HN009, NCT05050162: Comparing High-Dose Cisplatin Every Three Weeks to Low-Dose Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

Recruiting
2/3
464
Europe, Canada, US, RoW
Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation
NRG Oncology, National Cancer Institute (NCI)
Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma, Advanced Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of Unknown Primary
02/31
02/36
NCT04869475: Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation

Recruiting
2
20
RoW
Arsenic trioxide
Ruijin Hospital
Refractory Solid Tumors
04/22
04/24
NCT03126071: Raltitrexed-based Chemotherapy Plus Bevacizumab in Retreated Patients With Advanced Colorectal Cancer

Recruiting
2
100
RoW
Raltitrexed, Irinotecan, Oxaliplatin, Bevacizumab, Avastin
Jiangsu Cancer Institute & Hospital
Advanced Colorectal Cancer
08/22
02/23
ALTER-G-001, NCT05262335: Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis

Recruiting
2
116
RoW
Anlotinib + Oxaliplatin + Capecitabine, Anlotinib + Cisplatin + Paclitaxel/ Docetaxel, Anlotinib + Standard first-line chemotherapy
Ruijin Hospital, Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Gastrointestinal Tumors
12/23
12/24
NCT02710851: Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine

Active, not recruiting
2
640
NA
low dosage HPV Vaccine(1:1), low dosage HPV Vaccine(1:2), high dosage HPV Vaccine(1:1), Hepatitis E vaccine,Hecolin®
Jun Zhang, Xiamen Innovax Biotech Co., Ltd, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Condylomata Acuminata
12/23
12/23
ACHIEVE, NCT04808752: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases

Active, not recruiting
2
63
RoW
Almonertinib, Investigational Product
Zhejiang Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Lung Cancer
06/24
07/24
Ipat-Lung, NCT04467801: Ipatasertib and Docetaxel in Metastatic NSCLC Patients Who Have Failed 1st Line Immunotherapy

Recruiting
2
60
US
Ipatasertib
Jun Zhang, MD, PhD, University of Iowa, University of Kentucky
NSCLC Stage IV, NSCLC Stage IIIB
08/24
08/25
TQB2102-II-04, NCT06767800: A Clinical Trial Evaluating TQB2102 for Injection in Combination With Benmelstobart/Penpulimab With or Without Capecitabine in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma

Not yet recruiting
2
168
RoW
TQB2102 for injection+Benmelstobart, TQB2102 for injection+Benmelstobart+Capecitabine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Gastroesophageal Adenocarcinoma
09/26
09/27
Cabatezo-1, NCT05859217: A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC

Not yet recruiting
2
40
US
Cabozantinib, Cabometyx, Atezolizumab, Tecentriq
Jun Zhang, MD, PhD, Exelixis, Genentech, Inc.
Lung Cancer, NSCLC Stage IV, Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced NSCLC
06/26
06/28
CA239-0010, NCT05609578: Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

Recruiting
2
90
Europe, US, RoW
Adagrasib oral dose of 400 mg twice daily tablets, Pembrolizumab, Chemotherapy: Pemetrexed, Cisplatin/Carboplatin
Mirati Therapeutics Inc.
Advanced NSCLC, Metastatic Lung Cancer
06/26
12/26
TranStar102, NCT04495296: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Recruiting
1/2
320
RoW
TST001, Oxaliplatin, Capecitabine, Paclitaxel, Gemcitabine, Cisplatin, Nivolumab
Suzhou Transcenta Therapeutics Co., Ltd., Bristol-Myers Squibb
Advanced Cancer
02/25
05/25
NCT04781413: Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer

Recruiting
1/2
38
RoW
Nab-PTX, Sintilimab, S-1
Ruijin Hospital
Stage IIIC Gastric Cancer
03/24
03/24
CT041-ST-01, NCT04581473: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

Recruiting
1/2
192
RoW
CT041 autologous CAR T-cell injection, CAR T-cell injection, Physician's Choice（Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody）, Best support care(BSC)
CARsgen Therapeutics Co., Ltd., Peking University Cancer Hospital & Institute, Fudan University
Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma
06/24
06/38
NCT04440735: A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors

Active, not recruiting
1/2
125
US
DSP107, Atezolizumab
Kahr Medical
Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer
09/25
09/25
PRO1184-001, NCT05579366: Rinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ )

Recruiting
1/2
404
US, RoW
Rina-S, PRO1184, Rinatabart sesutecan, GEN1184, Carboplatin, Bevacizumab, Pembrolizumab
Genmab
Platinum-Resistant Ovarian Cancer, Platinum Sensitive Ovarian Cancer (PSOC), High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer, Endometrial Cancer, Non-small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Breast Adenocarcinoma, Triple Negative Breast Cancer, Hormone Receptor-positive/Her2 Negative Breast Cancer
04/26
10/26
NCT03236935: Phase Ib of L-NMMA and Pembrolizumab

Active, not recruiting
1
12
US
L-NMMA, NG-monomethyl-L-arginine, Pembrolizumab, Keytruda
The Methodist Hospital Research Institute
Non-Small Cell Lung Cancer, Malignant Melanoma, Head and Neck Squamous Cell Carcinoma, Classical Hodgkin Lymphoma, Urothelial Carcinoma Bladder, DNA Repair-Deficiency Disorders
10/21
12/24
Amaretto, NCT04981691: Anti-mesothelin CAR-T Cells With Advanced Refractory Solid Tumors

Recruiting
1
12
RoW
anti-MESO CAR T cells
Ruijin Hospital, UTC Therapeutics Inc.
Refractory Malignant Solid Neoplasm
01/22
07/22
NCT04731038: Combination Therapy for First Line Treatment of Advanced Cervical Cancer

Recruiting
1
20
RoW
Anlotinib, Toripalimab, Paclitaxel, Cisplatin/ Carboplatin
Ruijin Hospital
Advanced Cervical Cancer
07/22
07/24
McCrest-2, NCT04510818: Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 2)

Recruiting
1
20
RoW
Capecitabine, Camrelizumab
Ruijin Hospital
Head and Neck Cancer, Esophageal Squamous Cancer
08/22
08/24
NCT04508686: Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Recruiting
1
20
RoW
Capecitabine, camrelizumab
Ruijin Hospital
Advanced Cervical Cancer
08/22
08/24
DETECTOR-1, NCT04926753: Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer

Recruiting
1
20
RoW
5-Fluorouracil, Cisplatin, Toripalimab
Ruijin Hospital
Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
12/22
06/24
McCrest-3, NCT04932187: Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 3)

Recruiting
1
20
RoW
Capecitabine, Camrelizumab
Ruijin Hospital
Hepatobiliary, Pancreatic and Other Gastrointestinal Carcinoma (Non-stomach, Non-esophagi)
07/23
07/25
NCT05068856: A Study of HRS2543 in Patients With Advanced Tumors

Terminated
1
10
RoW
HRS2543
Shanghai Hengrui Pharmaceutical Co., Ltd.
Advanced Tumors
05/24
05/24
NCT05537987: Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid Tumors

Active, not recruiting
1
30
US
ICP-723
InnoCare Pharma Inc.
Advanced Solid Tumors
11/23
07/24
NCT04911166: Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy

Suspended
1
13
US
Atezolizumab and Interleukin-12 Gene Therapy
The Methodist Hospital Research Institute, Genentech, Inc.
Non-small Cell Lung Cancer
08/24
03/25
NCT04450732 / ACTRN12620000592943: Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Recruiting
1
96
US, RoW
GQ1001
GeneQuantum Healthcare (Suzhou) Co., Ltd., Conjugate Light (Australia) Pty Ltd
HER2-positive Breast Cancer, HER2-positive Biliary Tract Cancer, HER2-Positive Salivary Gland Carcinomas, HER2-Positive Advanced Solid Tumor
03/24
05/24
CIBI343A101, NCT05458219: A First-in-human Study of IBI343 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors

Recruiting
1
470
US, RoW
IBI343
Innovent Biologics (Suzhou) Co. Ltd., Innovent Biologics, Inc., TigerMed
Locally Advanced Unresectable or Metastatic Solid Tumors
12/25
12/25
NCT06566443: Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer

Not yet recruiting
1
15
US
Honokiol, Honopure (Dietary supplement)
The Methodist Hospital Research Institute
Carcinoma, Non-Small-Cell Lung
08/26
08/27
NCT05911217: A Study to Evaluate the Efficacy and Safety of CT041 After Adjuvant Chemotherapy for Pancreatic Cancer

Recruiting
1
20
RoW
CT041 autologous CAR T-cell injection, Single Group Assignment
CARsgen Therapeutics Co., Ltd., Fudan University
Pancreatic Cancer
12/26
12/26
NCT04617665: Effects of One-handed and Two-handed Mask Ventilation Techniques on Global and Regional Lung Ventilation

Not yet recruiting
N/A
80
NA
One-handed mask ventilation, Two-handed mask ventilation
Fudan University
Anesthesia
12/20
12/20
NCT04608240: Surgical Pleth Index: Predicting the Optimal Timing for Tracheal Intubation During General Anesthesia

Recruiting
N/A
102
RoW
Fudan University
Trachea Intubation
11/21
11/21
NCT04694495: HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study

Recruiting
N/A
10000
RoW
16S rRNA gene sequencing of cervical secretions, Microecology assessment of cervical secretions, Genotyping of HPV and detection of sexually transmitted diseases pathogens, Thinprep cytologic test of cervical exfoliated cells
Zhujiang Hospital, Peking University First Hospital, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, LanZhou University, Lianyungang Hospital Affiliated Bengbu Medical College, General Hospital of Ningxia Medical University, Jinan Central Hospital, Tibet Autonomous Region People's Hospital, The Affiliated Hospital Of Southwest Medical University, Anhui Provincial Hospital, The First People's Hospital of Zunyi, The Third Affiliated Hospital of Southern Medical University, First Affiliated Hospital, Sun Yat-Sen University, Zhuhai Center for Maternal and Child Health Care, First Affiliated Hospital of Guangxi Medical University, Qinghai Red Cross Hospital, Changzhi People's Hospital, Shanghai East Hospital, Fifth Affiliated Hospital of Guangzhou Medical University, Huizhou Municipal Central Hospital, Nanfang Hospital, Southern Medical University, Yuebei People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Fujian Maternity and Child Health Hospital, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Fifth Affiliated Hospital of Southern Medical University, Shandong Provincial Hospital, First Hospital of China Medical University, Gansu Provincial Hospital
Papillomavirus Infections, Uterine Cervical Neoplasms, Sexual Transmitted Disease
12/24
12/24
SIBLINT ISR, NCT04240444: Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

Completed
N/A
260
RoW
drug-coated balloon Catheter
B. Braun Medical International Trading Company Ltd., CCRF Inc., Beijing, China
Coronary Artery Disease, In Stent Restenosis
07/22
08/22
NCT04238338: Association of MLR With Risk of Death and Cardiovascular Events in PD Patients

Recruiting
N/A
266
RoW
monocyte / lymphocyte ratio
Zhujiang Hospital
Peritoneal Dialysis, Inflammation
06/22
06/22
NCT05299021: Serratus Anterior Plane Block for Modified Radical Mastectomy: Double-point VS Single-point

Completed
N/A
57
RoW
Double-point SAPB, Single-point SAPB
Fudan University
Mammary Cancer, Serratus Anterior Plane Block, Postoperative Pain
12/23
12/23
RESCUE-STEMI, NCT05354128: Thrombolysis in STEMI Patients Compared With pPCI on Recanalization Time in the Context of the COVID-19 Outbreak.

Recruiting
N/A
120
RoW
Thrombolytic, intravenous thrombolysis, percutaneous coronary stenting, PCI
Ya-Wei Xu
STEMI - ST Elevation Myocardial Infarction
11/22
04/23
TIPPR, NCT05155371: Titration of Intraoperative PEEP in Patients Undergoing Robotic Assisted Laparoscopic Prostatectomy

Completed
N/A
95
RoW
Titration of Optimal Positive End-expiratory Pressure
Fudan University
Positive End Expiratory Pressure
12/22
01/23
P6 and PONV, NCT05408676: Comparison of Dexamethasone Alone vs in Combination With Pericardium 6 (P6) Electrical Stimulation or Granisetron in the Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Breast Cancer Surgery

Completed
N/A
198
RoW
electric stimulation therapy
Fudan University
Mammary Cancer, PONV
03/23
05/23
AF-PACC-CRYO, NCT05311098: Cryoablation With Vestibular Expansion for the Treatment of Paroxysmal/Short-course Persistent Atrial Fibrillation

Recruiting
N/A
400
RoW
cryoablation
Shanghai 10th People's Hospital
Atrial Fibrillation
05/23
05/24
SMEE, NCT05401045: Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric Cancer

Completed
N/A
119
RoW
Met exercises
Ruijin Hospital
Neoplasm of Stomach
06/23
07/23
NCT05148663: CCM Blood Biomarker Validation Study

Terminated
N/A
12
US
CCM Hemorrhagic Panel
Texas Tech University Health Sciences Center, El Paso
Hemorrhagic Stroke, Intracerebral, Cerebral Cavernous Malformation
08/23
08/23
NCT04636775: Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)

Recruiting
N/A
46
US
Microbiome
Jun Zhang, MD, PhD
NSCLC Stage IV, NSCLC, Recurrent
08/24
12/24
NCT04529265: Methylene Blue and Postoperative Neurocognitive Disorders

Completed
N/A
314
RoW
Methylene Blue, Placebo
Fudan University
Postoperative Delirium, Postoperative Cognitive Dysfunction
04/23
10/23
NCT06081647: The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure

Not yet recruiting
N/A
1200
RoW
the COMBO Endoscopy Oropharyngeal Airway, Regular Nasal Cannula
RenJi Hospital, Tianjin Medical University General Hospital, The First Affiliated Hospital with Nanjing Medical University, First Affiliated Hospital Xi'an Jiaotong University, Qianfoshan Hospital, Fudan University
Hypoxia, Gastric Polyp, Colon Cancer, Esophageal Cancer
10/23
10/24
NCT06143020: Effect of ESPB on Postoperative Pain in Patients With Breast Cancer Implant Reconstruction

Completed
N/A
100
RoW
Erector spinae plane block, Ultrasound-guided erector spinae plane block
Fudan University
Mammary Cancer, Erector Spinae Plane Block, Postoperative Pain
03/24
03/24
Microdurva, NCT04680377: Using Microbiome to Predict Durvalumab Toxicity in Post- Concurrent Chemoradiation Therapy (CCRT) NSCLC Patients

Recruiting
N/A
44
US
Jun Zhang, MD, PhD, Rhode Island Hospital
NSCLC, Stage III, Locally Advanced Lung Carcinoma
12/25
12/26
NCT06197802: Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women

Active, not recruiting
N/A
392
RoW
Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58 )Vaccine(E.Coli), Gardasil®9
Xiamen University, Xiamen Innovax Biotech Co., Ltd, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Cervical Cancer, Condylomata Acuminata
03/25
03/25
CONTROL-AF, NCT05311137: Study of the Closed-loop Treatment Concept of Atrial Fibrillation in the Atrial Fibrillation Population

Recruiting
N/A
5000
RoW
Radiofrequency ablation, cryoablation;, left bundle branch pacing;, left atrial appendage occlusion;
Shanghai 10th People's Hospital
Atrial Fibrillation
01/24
01/32
TUMORIN, NCT05332925: Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

Recruiting
N/A
25
US
Standard of care immune checkpoint inhbitors
Jun Zhang, MD, PhD, Nilogen Oncosystems
Lung Cancer, NSCLC, NSCLC Stage IV
01/26
02/27
NCT03456895: Assessing Environmental Factors in Healthcare Facilities in Order to Improve the Experience of Patients, Staff, and the Quality of Imaging Procedures

Active, not recruiting
N/A
15
US
Light perception, Sound perception, Smell perception, Vibration perception, Voice activation
University of Cincinnati, Ohio Third Frontier, Wright Center of Innovation in Biomedical Imaging
Healthcare Facility Environment - Imaging
12/24
12/24
HPV-PRO-006-4, NCT06243666: Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls

Not yet recruiting
N/A
2188
RoW
Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli), No intervention
Xiamen University, Xiamen Innovax Biotech Co., Ltd, Center for Disease Control and Prevention, Sheyang County, Yancheng City, Jiangsu Province, China
Cervical Intraepithelial Neoplasia, Cervical Cancer, Persistent Infection
12/26
12/26
NCT06120439: Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy

Completed
N/A
96
RoW
PECS II combined with intercostal nerve blockade;, General anesthesia with laryngeal mask
Jun Zhang
Breast Cancer, Pectoral Nerves Block, Breast-Conserving Surgery, Sentinel Lymph Node Biopsy
05/24
05/24
NCT06507683: Evaluate the Efficacy and Safety of Radiotherapy Combined With Ripretinib in the Treatment of Unresectable Advanced GIST

Recruiting
N/A
32
RoW
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
First Affiliated Hospital of Chongqing Medical University, Peking University Cancer Hospital & Institute
Gastrointestinal Stromal Tumors
07/27
07/27
NCT06561633: The Influence Factors of Bispectral Index Values Increment Caused by Sugammadex

Completed
N/A
135
RoW
Sugammadex administration, BIS monitor
Jun Zhang
BIS
09/24
09/24
NCT06035250: AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy

Recruiting
N/A
200
Europe, RoW
Neoadjuvant Chemotherapy
Chinese Academy of Sciences, Peking University Cancer Hospital & Institute, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Yunnan Cancer Hospital, Henan Cancer Hospital, Zhenjiang First People's Hospital, First Hospital of China Medical University, Cancer Hospital of Guangxi Medical University, Peking University People's Hospital, Tianjin Medical University Cancer Institute and Hospital, The First Affiliated Hospital of Zhengzhou University, Nanfang Hospital, Southern Medical University, The Affiliated Hospital of Qingdao University, Ruijin Hospital, Sixth Affiliated Hospital, Sun Yat-sen University, Peking Union Medical College Hospital, Xiangya Hospital of Central South University, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, The First Affiliated Hospital of Soochow University, First Affiliated Hospital, Sun Yat-Sen University, Fujian Medical University Union Hospital, Fujian Cancer Hospital, San Raffaele University Hospital, Italy
Gastric Cancer, Image, Pathology
08/24
12/29
NCT05649488: Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus

Recruiting
N/A
184
RoW
Intracoronary lithotripsy balloon catheter and Intracoronary lithotripsy apparatus, Dragonfly Opstar Imaging Catheter
Shanghai Bluesail Boyuan Medical Technology Co., Ltd.
Coronary Artery Disease, Intravascular Lithotripsy
12/24
09/25
NCT03491046: Molecular Imaging Assessment of ACL Viability

Active, not recruiting
N/A
66
US
PET scan, MRI scan
University of Cincinnati
ACL Injury
12/24
12/24
NCT03490812: Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging

Active, not recruiting
N/A
131
US
PET scan, Retrospective data analysis
University of Cincinnati
PET Imaging
12/24
12/24
NCT03519659: Validating Low FDG Dose PET/CT Compared to Current Standard of Care Dose PET/CT

Active, not recruiting
N/A
190
US
PET/CT scan with 13 mCi radiation dose, PET/CT scan with 5 mCi radiation dose, PET/CT scan with 2.5 mCi radiation dose, PET/CT Scan with 6.5 mCi radiation dose, PET/CT Scan with not yet determined radiation dose
University of Cincinnati, National Cancer Institute (NCI), Ohio Third Frontier
PET/CT Imaging
12/24
12/24
NCT03490656: Assessment of Investigational Magnetic Resonance Imaging and Post-Processing Procedures

Active, not recruiting
N/A
77
US
MRI Scan - in addition to standard of care, MRI Scan - not in addition to standard of care
University of Cincinnati
MRI Imaging
12/24
12/24
NCT03387618: Feasibility Assessment of Next-generation PET Technology and Procedures

Active, not recruiting
N/A
408
US
Digital PET/CT imaging
University of Cincinnati, Ohio Third Frontier
New-generation Digital PET/CT Imaging
12/24
12/24
NCT05866029: Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

Recruiting
N/A
2478
RoW
Denosumab, Teriparatide
Peking Union Medical College Hospital
Osteoporotic Fractures
09/26
09/26
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
ALCHEMIST Screening, NCT02194738: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The Trial)

Recruiting
N/A
8300
US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Clinical Observation, observation, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Crizotinib, Alkixen, Crizocent, MET Tyrosine Kinase Inhibitor PF-02341066, PF 02341066, PF-02341066, PF-2341066, PF02341066, Xalkori, Cytology Specimen Collection Procedure, Cytologic Sampling, Echocardiography, EC, Erlotinib, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemcitabine HCI, Gemzar, LY 188011, LY-188011, LY188011, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK 3475, MK-3475, MK3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, Pembrolizumab Biosimilar RPH-075, QL2107, RPH 075, RPH-075, RPH075, SCH 900475, SCH-900475, SCH900475, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Placebo Administration, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Cancer AJCC v8
09/26
09/26
WIIA, NCT05074537: The Wright Center of Innovation Imaging Archive

Active, not recruiting
N/A
10000
US
MRI exam, PET/CT imaging exam, CT imaging exam
University of Cincinnati
Medical Imaging Data
05/28
05/30
NCT04440605: A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis

Recruiting
N/A
968
RoW
Preoperative staging——D2 gastrectomy——Postoperative staging
Peking University, RenJi Hospital, Ruijin Hospital, West China Hospital, Beijing 302 Hospital, Fudan University, Peking University International Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Fujian Medical University Union Hospital, First Affiliated Hospital Xi'an Jiaotong University, Chinese PLA General Hospital, First Affiliated Hospital of Xinjiang Medical University, Tianjin Medical University General Hospital, The Second Affiliated Hospital of Dalian Medical University, Wuhan Union Hospital, China, Peking University People's Hospital, Weifang People's Hospital, Second Hospital of Jilin University, Fujian Province Tumor Hospital, Shanxi Province Cancer Hospital, The First Affiliated Hospital of Nanchang University, Tianjin Medical University Cancer Institute and Hospital, Shanghai Zhongshan Hospital, First Affiliated Hospital, Sun Yat-Sen University, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Xiamen University, Beijing Hospital, Beijing Friendship Hospital, Qingdao Municipal Hospital, Guangdong Provincial People's Hospital, Affiliated Hospital of Qinghai University, Shandong Provincial Hospital, First Hospital of Jilin University, Nanfang Hospital of Southern Medical University, Zhongshan Hospital Xiamen University, Hebei Medical University Fourth Hospital
Gastric Cancer, Gastric Cancer Stage, CT, Neoadjuvant Therapy
04/22
10/22
NCT04520295: ctDNA Screening in Advanced HER2 Positive Gastric Cancer

Recruiting
N/A
100
RoW
ctDNA screening
Ruijin Hospital
HER2-positive Gastric Cancer
05/23
05/25

Download Options